17-DMAG

Hsp90 inhibitor

Catalog No. SIH-114

0 out of 5 based on 0 customer ratings
CAS No. 467214-20-6
Molecular Formula C32H48N4O8
SKU: SIH-114 Categories: ,

Clear
SIH-114_17-DMAG_Chemical_Structure.png
Product Name 17-DMAG
Description

Hsp90 inhibitor

Purity >98% (TLC); NMR (Conforms)
CAS No. 467214-20-6
Molecular Formula C32H48N4O8
Molecular Weight 616.8
Field of Use Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

Properties

Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Inhibitor
Solubility Soluble in DMSO (30 mg/ml) and ethanol (10 mg/ml)
Source Synthetic
Appearance Purple Solid
SMILES C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCCN(C)C)/C)OC)OC(=O)N)C)C)O)OC
InChI InChI=1S/C32H48N4O8/c1-18-14-22-27(34-12-13-36(5)6)24(37)17-23(29(22)39)35-31(40)19(2)10-9-11-25(42-7)30(44-32(33)41)21(4)16-20(3)28(38)26(15-18)43-8/h9-11,16-18,20,25-26,28,30,34,38H,12-15H2,1-8H3,(
InChIKey KUFRQPKVAWMTJO-LMZWQJSESA-N
Safety Phrases Classification: Caution: Substance not yet fully tested.
Safety Phrases:
S22 - Do not breathe dust
S24/25 - Avoid contact with skin and eyes
S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection
Cite This Product 17-DMAG (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-114)

Biological Description

Alternative Names Alvespimycin, 17DMAG, 17-(dimethylaminoethylamino)-17-demethoxy-geldanamycin, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin, 17-desmethoxy-17-n,n-dimethylaminoethylamino-geldanamycin, 17-dimethylaminoethylamino-17-demethoxy-geldanamycin, 17-DMAG, 17-Dimethylaminoethylamino, 17-Demethoxygeldanamycin, [(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-21-[2-(dimethylamino)ethylamino]-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate
Research Areas Cancer, Heat Shock
PubChem ID 5288674
Scientific Background 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin) is a water-soluble, bioavailable analog of geldanamycin and 17-AAG, designed to overcome the solubility and toxicity limitations of its predecessors. As a high-affinity HSP90 inhibitor, 17-DMAG disrupts the stability of client proteins involved in neurodegenerative disease pathways. Preclinical studies highlight its ability to induce autophagy and promote the clearance of alpha-synuclein aggregates, a hallmark of Parkinson’s disease and related disorders. Its favorable pharmacokinetic profile, including efficient tissue distribution and reduced metabolic degradation, makes 17-DMAG a compelling candidate for CNS-targeted therapies. By enhancing proteostasis and mitigating protein aggregation, 17-DMAG represents a promising tool for modulating neurodegenerative processes at the molecular chaperone level.
References 1. Bull E.E., et al.(2004) Clin. Cancer Res. 10: 8077.
2. Gossett D.R. et al.(2005) Gynecol. Oncol. 96: 381.
3. Kaur G. et al.(2004) Clin. Cancer Res. 10: 4813.

Product Images

<p>Chemical structure of 17-DMAG (SIH-114), a Hsp90 inhibitor. CAS #: 467214-20-6. Molecular Formula: C32H48N4O8. Molecular Weight: 616.8 g/mol.</p>

Chemical structure of 17-DMAG (SIH-114), a Hsp90 inhibitor. CAS #: 467214-20-6. Molecular Formula: C32H48N4O8. Molecular Weight: 616.8 g/mol.

Reviews

Reviews

There are no reviews yet.

Be the first to review “17-DMAG”

Your email address will not be published. Required fields are marked *